These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 7638554)

  • 21. Association of coagulation factor VII with the risk of myocardial infarction in the Chinese.
    Cai Q; Chen J; Ma H; Song J; Xu M
    Chin Med J (Engl); 2000 Dec; 113(12):1059-63. PubMed ID: 11776135
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Purification and characterization of factor VII 304-Gln: a variant molecule with reduced activity isolated from a clinically unaffected male.
    O'Brien DP; Gale KM; Anderson JS; McVey JH; Miller GJ; Meade TW; Tuddenham EG
    Blood; 1991 Jul; 78(1):132-40. PubMed ID: 2070047
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Factor VIIShinjo: a dysfunctional factor VII variant homozygous for the substitution Gln for Arg at position 79.
    Takamiya O; Abe S; Yoshioka A; Nakajima K; McVey JH; Tuddenham EG
    Haemostasis; 1995; 25(3):89-97. PubMed ID: 7607584
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A novel factor X mutation Cys81 by Arg and a reported factor VII polymorphism Arg353 replaced by Gln co-occured in a patient.
    Jin Y; Cheng X; Zheng J; Xia H; Yang L; Wang M
    Blood Coagul Fibrinolysis; 2018 Jan; 29(1):67-74. PubMed ID: 29251640
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Analysis of Phenotype and Genotypein an Inherited Coagulation Factor VII Deficiency Pedigree.
    Li M; Jin Y; Wang M; Ding H
    Clin Lab; 2019 Dec; 65(12):. PubMed ID: 31850724
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Polymorphisms of the factor VII gene and circulating FVII:C levels in relation to acute cerebrovascular disease and poststroke mortality.
    Heywood DM; Carter AM; Catto AJ; Bamford JM; Grant PJ
    Stroke; 1997 Apr; 28(4):816-21. PubMed ID: 9099202
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Angiotensin-converting enzyme insertion/deletion genotype is associated with the activities of plasma coagulation factor VII and X independent of triglyceride metabolism.
    Okura Y; Hayashi K; Shingu T; Kuga Y; Nomura S; Kajiyama G; Nakashima Y; Saku K
    Coron Artery Dis; 2003 Jun; 14(4):285-91. PubMed ID: 12826927
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Contribution of factor VII genotype to activated FVII levels. Differences in genotype frequencies between northern and southern European populations.
    Bernardi F; Arcieri P; Bertina RM; Chiarotti F; Corral J; Pinotti M; Prydz H; Samama M; Sandset PM; Strom R; Garcia VV; Mariani G
    Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):2548-53. PubMed ID: 9409226
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Study on plasma coagulation factor VII (FVII) levels and polymorphisms of FVII gene in patients with coronary heart disease].
    Kang W; Wang H; Xiong L; Wang X; Chu H; Qu B; Liu X; Yin J; Duan B; Yu J; Wang Z
    Zhonghua Xue Ye Xue Za Zhi; 2002 Sep; 23(9):457-9. PubMed ID: 12482354
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Genotype and phenotype analysis of congenital coagulator factor VII deficiency in four Chinese pedigrees].
    Jiang MH; Wang ZY; Yu ZQ; Bai X; Cao LJ; Su J; Sun XH; Zhang W; Ruan CG
    Zhonghua Xue Ye Xue Za Zhi; 2011 Mar; 32(3):147-52. PubMed ID: 21535950
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A common genetic polymorphism associated with lower coagulation factor VII levels in healthy individuals.
    Green F; Kelleher C; Wilkes H; Temple A; Meade T; Humphries S
    Arterioscler Thromb; 1991; 11(3):540-6. PubMed ID: 1709359
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genotype-phenotype relationship of F7 R353Q polymorphism and plasma factor VII coagulant activity in Asian Indian families predisposed to coronary artery disease.
    Shanker J; Perumal G; Maitra A; Rao VS; Natesha BK; John S; Hebbagodi S; Kakkar VV
    J Genet; 2009 Dec; 88(3):291-7. PubMed ID: 20086294
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A patient homozygous for a Gly354Cys mutation in factor VII that results in severely impaired secretion of the molecule, but not complete deficiency.
    Takamiya O; Hino K
    Br J Haematol; 2004 Feb; 124(3):336-42. PubMed ID: 14717781
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Plasminogen activator inhibitor-1 4G/5G promoter polymorphism and coagulation factor VII Arg353-->Gln polymorphism in Korean patients with coronary artery disease.
    Song J; Yoon YM; Jung HJ; Hong SH; Park H; Kim JQ
    J Korean Med Sci; 2000 Apr; 15(2):146-52. PubMed ID: 10803689
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Elevated levels of factor VII activity in the postprandial state: effect of the factor VII Arg-Gln polymorphism.
    Silveira A; Green F; Karpe F; Blombäck M; Humphries S; Hamsten A
    Thromb Haemost; 1994 Nov; 72(5):734-9. PubMed ID: 7900081
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Coagulation factor VII, R353Q polymorphism, and serum choline-containing phospholipids in males at high risk for coronary heart disease.
    Lindman AS; Pedersen JI; Arnesen H; Hjerkinn EM; Veierød MB; Prydz H; Seljeflot I
    Thromb Res; 2004; 113(1):57-65. PubMed ID: 15081566
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Coagulation factor VII and plasma triglycerides. Decreased catabolism as a possible mechanism of factor VII hyperactivity.
    Carvalho de Sousa J; Bruckert E; Giral P; Soria C; Chapman J; Truffert J; Dairou F; De Gennes JL; Caen JP
    Haemostasis; 1989; 19(3):125-30. PubMed ID: 2744628
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The study of gene-environment interactions that influence thrombosis and fibrinolysis. Genetic variation at the loci for factor VII and plasminogen activator inhibitor-1.
    Humphries SE; Lane A; Dawson S; Green FR
    Arch Pathol Lab Med; 1992 Dec; 116(12):1322-9. PubMed ID: 1456879
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of dietary fat modification on fibrinogen, factor VII, and plasminogen activator inhibitor-1 activity in subjects with impaired glucose tolerance.
    Niskanen L; Schwab US; Sarkkinen ES; Krusius T; Vahtera E; Uusitupa MI
    Metabolism; 1997 Jun; 46(6):666-72. PubMed ID: 9186303
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Coagulation factor VII activity, Arg/Gln353 polymorphism and features of insulin resistance in first-degree-relatives of South Asian patients with stroke.
    Kain K; Catto AJ; Young J; Bamford J; Bavington J; Grant PJ
    Thromb Haemost; 2002 Dec; 88(6):954-60. PubMed ID: 12529745
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.